Cetrorelix Acetate NEW
| Price | $40 | $77 | $123 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Cetrorelix Acetate | CAS No.: 145672-81-7 |
| Purity: 97.96% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Cetrorelix Acetate |
| Description | Cetrorelix Acetate is gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM. |
| In vitro | GnRH-I antagonist Cetrorelix inhibited growth of ES-2 cell line only at 1000 ng/ml.?The incubation of ES-2 ovarian cancer cells in vitro with an GnRH-I antibody inhibited cell proliferation in a time and concentration-dependent manner.?GnRH-I may function as an autocrine growth factor in this ovarian cancer cell line [1]. |
| In vivo | Cetrorelix inhibits the activation of hGnRHR and a downstream luciferase reporter gene in murine LTK- cells by the GnRHR agonist [D-Trp6]GnRH (IC50 = 1.2 nM). In vivo, cetrorelix (60 μg per day) reduces tumor volume to 35% of control and decreases serum luteinizing hormone levels by 50% in a human epithelial ovarian cancer mouse xenograft model[2]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 50 mg/mL (33.53 mM) |
| Keywords | SB-75 | GnRH Receptor | Cetrorelix Acetate | Inhibitor | SB 75 | Gonadotropin releasing hormone receptor | inhibit | SB75 | GNRHR |
| Inhibitors Related | Histrelin acetate | Nafarelin acetate(76932-56-4 free base) | Relugolix | Deslorelin acetate(57773-65-6 free base) | Ganirelix Acetate | Opigolix | Linzagolix choline | LGnRH-III, lamprey acetate(147859-97-0 free base) | Alarelin Acetate | Cetrorelix diacetate | Lecirelin acetate(61012-19-9 free base) | AG 045572 |
| Related Compound Libraries | Approved Drug Library | Anti-Cancer Clinical Compound Library | Peptide Compound Library | Drug Repurposing Compound Library | NO PAINS Compound Library | Anti-Cancer Approved Drug Library | Clinical Compound Library | Anti-Cancer Compound Library | Human Metabolite Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1box |
VIP1Y
|
Shandong Huizhihan Supply Chain Co., Ltd
|
2024-10-31 | |
| $15.00/1g |
Longyan Tianhua Biological Technology Co., Ltd
|
2020-10-27 | ||
| $7.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2019-07-04 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY